Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

R1 Rcm Inc (RCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 946,928
  • Shares Outstanding, K 109,980
  • Annual Sales, $ 449,800 K
  • Annual Income, $ -58,800 K
  • 36-Month Beta -0.76
  • Price/Sales 1.98
  • Price/Cash Flow N/A
  • Price/Book 37.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.91 +8.72%
on 10/15/18
10.39 -17.23%
on 10/01/18
-0.86 (-9.09%)
since 09/17/18
3-Month
7.57 +13.61%
on 07/30/18
11.00 -21.82%
on 09/04/18
-0.19 (-2.16%)
since 07/17/18
52-Week
3.56 +141.57%
on 11/10/17
11.00 -21.82%
on 09/04/18
+4.97 (+136.91%)
since 10/17/17

Most Recent Stories

More News
New Research Coverage Highlights R1 RCM, Synchronoss Technologies, Carbonite, Solaris Oilfield Infrastructure, Canadian Solar, and Northern Dynasty Minerals -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of R1 RCM Inc. (NASDAQ:RCM), Synchronoss...

CARB : 35.95 (+0.03%)
CSIQ : 14.97 (-1.25%)
NAK : 0.52 (-3.31%)
SNCR : 6.23 (+2.13%)
SOI : 17.21 (-3.04%)
RCM : 8.60 (-0.12%)
R1 RCM to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference

R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will present at the Cantor Fitzgerald...

RCM : 8.60 (-0.12%)
KEPRO Names Joel Portice Chief Executive Officer To Lead Company In Next Phase Of Growth

KEPRO, a leading medical management and cost containment solution provider for government and commercial payers in the healthcare sector, today announced that Joel Portice has been named the company's...

RCM : 8.60 (-0.12%)
R1 RCM to Present at the Baird 2018 Global Healthcare Conference

R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will present at the Baird 2018 Global...

RCM : 8.60 (-0.12%)
Intermedix, an R1 Company, Recognized by Forbes as One of America's Best Employers for Women

Intermedix, an R1 company, and a global leader in the health care information technology industry, has been named one of 2018 America's Best Employers for Women by Forbes. Earlier this year, Intermedix...

RCM : 8.60 (-0.12%)
Market Trends Toward New Normal in Esperion Therapeutics, Oxford Immunotec Global, Limoneira, R1 RCM, Carbonite, and Shenandoah Telecommunications -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Esperion Therapeutics, Inc....

ESPR : 49.94 (+0.06%)
CARB : 35.95 (+0.03%)
OXFD : 16.98 (+2.10%)
LMNR : 25.68 (+1.54%)
SHEN : 38.84 (+2.02%)
RCM : 8.60 (-0.12%)
R1 RCM Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2018 / R1 RCM Inc (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 8:00 AM Eastern Time.

RCM : 8.60 (-0.12%)
R1 RCM to Release Second Quarter 2018 Results on August 9

R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three...

RCM : 8.60 (-0.12%)
R1 RCM Reports First Quarter 2018 Results

R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended March 31, 2018.

RCM : 8.60 (-0.12%)
R1 Closes Acquisition of Intermedix Corporation

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it has completed its acquisition of Intermedix Corporation....

RCM : 8.60 (-0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade RCM with:

Business Summary

R1 RCM Inc. offers financial services for the health care industries. The Company provides revenue cycle management and physician advisory services, as well as transforms and manages the commercial infrastructure of health care organizations. R1 RCM Inc., formerly known as Accretive Health, Inc., is...

See More

Key Turning Points

2nd Resistance Point 8.83
1st Resistance Point 8.71
Last Price 8.60
1st Support Level 8.42
2nd Support Level 8.25

See More

52-Week High 11.00
Last Price 8.60
Fibonacci 61.8% 8.16
Fibonacci 50% 7.28
Fibonacci 38.2% 6.40
52-Week Low 3.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar